Statins moderate coronary stenoses but not coronary calcification: Results from meta-analyses

International Journal of Cardiology

Volumn 153, Issue 1, 2011, Pages 31-35

  Henein, Michael Y ^a,b   Owen, Andrew ^b,c  

^a UMEÅ UNIVERSITY   (Sweden)

^b CANTERBURY CHRIST CHURCH UNIVERSITY   (United Kingdom)

^c PRINCESS OF WALES HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; Coronary calcification; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY OBSTRUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DYSLIPIDEMIA; HUMAN; LIPID BLOOD LEVEL; LOW DRUG DOSE; MAJOR CLINICAL STUDY; META ANALYSIS; MOLECULAR PATHOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS;

CALCINOSIS; CARDIOMYOPATHIES; CHOLESTEROL, LDL; CORONARY STENOSIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 81055144260     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.08.031     Document Type: Article

References (23)

1. S.E. Nissen, E.M. Tuzcu, P. Schoenhagen REVERSAL Investigators Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial JAMA 291 2004 1071 1080
2. D. Waters, L. Higginson, and P. Gladstone Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. Circulation 89 1994 959 968
3. R. Erbel, and J.A. Delaney Multi-Ethnic Study of Atherosclerosis; Investigator Group of the Heinz Nixdorf Recall Study. Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR) Eur Heart J 29 2008 2782 2791
4. A. Schmermund, S. Möhlenkamp, and D. Baumgart Usefulness of topography of coronary calcium by electron-beam computed tomography in predicting the natural history of coronary atherosclerosis Am J Cardiol 86 2000 127 132
5. U. Hoffmann, U. Siebert, and A. Bull-Stewart Evidence for lower variability of coronary artery calcium mineral mass measurements by multi-detector computed tomography in a community-based cohort-consequences for progression studies Eur J Radiol 57 2006 396 402
6. S. Achenbach, D. Ropers, and K. Pohle Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation Circulation 106 2002 1077 1082
7. D.V. Anand, E. Lim, and D. Darko Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers J Am Coll Cardiol 50 2007 2218 2225
8. D. Moher, D.J. Cook, and S. Eastwood Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354 1999 1896 1900
9. R.J. Hardy, and S.G. Thompson Detecting and describing heterogeneity in meta-analysis Stat Med 171 1998 841 856
10. Y. Arad, L.A. Spadaro, M. Roth, D. Newstein, and A.D. Guerci Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial J Am Coll Cardiol 46 2005 166 172
11. E.S. Houslay, S.J. Cowell, R.J. Prescott Scottish Aortic Stenosis and Lipid Lowering Therapy, Impact on Regression trial Investigators Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial Heart 92 2006 1207 1212
12. P. Raggi, M. Davidson, and T.Q. Callister Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) Circulation 112 2005 563 571
13. A. Schmermund, S. Achenbach, and T. Budde Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial Circulation 113 2006 427 437
14. J.G. Terry, J.J. Carr, and E.O. Kouba Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the coronary artery calcification treatment with zocor [CATZ] study) Am J Cardiol 99 2007 1714 1717
15. G. Brown, J.J. Albers, and L.D. Fisher Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B N Engl J Med 323 1990 1289 1298
16. J.A. Herd, C.M. Ballantyne, and J.A. Farmer Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]) Am J Cardiol 80 1997 278 286
17. K. Mizuno, H. Nakamura JUST Study Investigators A randomized, open-label, comparative study of simvastatin plus diet versus diet alone on angiographic retardation of coronary atherosclerosis in adult Japanese patients: Japanese utilization of simvastatin therapy (JUST) study Clin Ther 26 2004 878 888
18. T. Yamada, A. Azuma, S. Sasaki REACH Study Group Randomized evaluation of atorvastatin in patients with coronary heart disease: a serial intravascular ultrasound study Circ J 71 2007 1845 1850
19. D. Follmann, P. Elliott, I. Suh, and J. Cutler Variance imputation for overviews of clinical trials with continuous response J Clin Epidemiol 45 1992 769 773
20. A. Zambon, J.E. Hokanson, G. Brown, and J.D. Brunzell Evidence for a new pathophysiological mechanism for coronary artery disease regression Circulation 1999 1959 1964
21. A.B. Rossebø, T.R. Pedersen, K. Boman SEAS Investigators Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis N Engl J Med 359 2008 1343 1356
22. M.J. Budoff, D. Yu, and K. Nasir Diabetes and progression of coronary calcium under the influence of statin therapy Am Heart J 149 2005 695 700
23. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150